Eugenio Fardella (E Fardella)

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 16

Top Venues

Nature medicine

Blood advances

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Eugenio Fardella, G Zanirato, M Magni, N Caldarelli, Annalisa Chiappella, A Dodero, S Ljevar, L Orsucci, A Re, S V Usai, V Stefoni, C Castellino, F G Rossi, Antonello Pinto, Cristiana Carniti, Paolo Corradini
Prognostic impact of pretreatment cell-free DNA concentration in newly diagnosed peripheral T-cell lymphomas. British journal of haematology 204 (5) (2024)
Cristiana Carniti, Nicole Maria Caldarelli, Luca Agnelli, Tommaso Torelli, Silva Ljevar, Sadhana Jonnalagadda, Giada Zanirato, Eugenio Fardella, Federico Stella, Daniele Lorenzini, Silvia Brich, Flavio Arienti, Anna Dodero, Annalisa Chiappella, Martina Magni, Paolo Corradini
Monocytes in leukapheresis products affect the outcome of CD19-targeted CAR T-cell therapy in lymphoma patients. Blood advances (2024)
Cristiana Carniti, Nicole Maria Caldarelli, Luca Agnelli, Tommaso Torelli, Silva Ljevar, Sadhana Jonnalagadda, Giada Zanirato, Eugenio Fardella, Federico Stella, Daniele Lorenzini, Silvia Brich, Flavio Arienti, Anna Dodero, Annalisa Chiappella, Martina Magni, Paolo Corradini
Monocytes in leukapheresis products affect the outcome of CD19-targeted CAR T-cell therapy in patients with lymphoma. Blood advances 8 (8) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine 30 (4) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine 30 (4) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine 30 (4) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T-cell Lymphoma and Secondary Primary Malignancy Risk After Commercial CAR T-cell Therapy. Nature medicine (2024)
Cristiana Carniti, Nicole Maria Caldarelli, Luca Agnelli, Tommaso Torelli, Silva Ljevar, Sadhana Jonnalagadda, Giada Zanirato, Eugenio Fardella, Federico Stella, Daniele Lorenzini, Silvia Brich, Flavio Arienti, Anna Dodero, Annalisa Chiappella, Martina Magni, Paolo Corradini
Monocytes in leukapheresis products affect the outcome of CD19-targeted CAR T-cell therapy in patients with lymphoma. Blood advances 8 (8) (2024)
Cristiana Carniti, Nicole Maria Caldarelli, Luca Agnelli, Tommaso Torelli, Silva Ljevar, Sadhana Jonnalagadda, Giada Zanirato, Eugenio Fardella, Federico Stella, Daniele Lorenzini, Silvia Brich, Flavio Arienti, Anna Dodero, Annalisa Chiappella, Martina Magni, Paolo Corradini
Monocytes in leukapheresis products affect the outcome of CD19-targeted CAR T-cell therapy in patients with lymphoma. Blood advances 8 (8) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine 30 (4) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine (2024)
Eugenio Fardella, G Zanirato, M Magni, N Caldarelli, Annalisa Chiappella, A Dodero, S Ljevar, L Orsucci, A Re, S V Usai, V Stefoni, C Castellino, F G Rossi, Antonello Pinto, Cristiana Carniti, Paolo Corradini
Prognostic impact of pretreatment cell-free DNA concentration in newly diagnosed peripheral T-cell lymphomas. British journal of haematology (2024)
Cristiana Carniti, Nicole Maria Caldarelli, Luca Agnelli, Tommaso Torelli, Silva Ljevar, Sadhana Jonnalagadda, Giada Zanirato, Eugenio Fardella, Federico Stella, Daniele Lorenzini, Silvia Brich, Flavio Arienti, Anna Dodero, Annalisa Chiappella, Martina Magni, Paolo Corradini
Monocytes in leukapheresis products affect the outcome of CD19-targeted CAR T-cell therapy in patients with lymphoma. Blood advances 8 (8) (2024)
Eugenio Fardella, G Zanirato, M Magni, N Caldarelli, Annalisa Chiappella, A Dodero, S Ljevar, L Orsucci, A Re, S V Usai, V Stefoni, C Castellino, F G Rossi, Antonello Pinto, Cristiana Carniti, Paolo Corradini
Prognostic impact of pretreatment cell-free DNA concentration in newly diagnosed peripheral T-cell lymphomas. British journal of haematology 204 (5) (2024)
Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivanna M Van Deerlin, Jennifer J D Morrissette, Gabriel C Caponetti, Luca Paruzzo, Jaryse C Harris, Elise A Chong, Sandra P Susanibar-Adaniya, Jakub Svoboda, Sunita D Nasta, Ositadimma H Ugwuanyi, Daniel J Landsburg, Eugenio Fardella, Adam J Waxman, Emeline R Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David B Lieberman, Adam David Cohen, Bruce L Levine, Edward A Stadtmauer, Noelle V Frey, Dan T Vogl, Elizabeth O Hexner, Stefan K Barta, David L Porter, Alfred L Garfall, Stephen J Schuster, Carl H June, Marco Ruella
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature medicine (2024)

Eugenio Fardella.css-eqlu8i{font-size:small;padding-left:4px;} (E Fardella)

Publication Activity (10 Years)

Top Topics

Top Venues

Eugenio Fardella (E Fardella)